Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS

Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
Xiao-fei Zhou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linping Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Tseng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Scott-Ramsay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerome J. Schentag
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. Coburn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilyn E. Morris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 3 321-328
DOI 
https://doi.org/10.1124/dmd.104.002089
PubMed 
15585608

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received August 28, 2004
  • Accepted December 2, 2004
  • Published online February 14, 2005.

Article Versions

  • Earlier version (December 7, 2004 - 11:33).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Xiao-fei Zhou,
  2. Linping Zhang,
  3. Elaine Tseng,
  4. Elizabeth Scott-Ramsay,
  5. Jerome J. Schentag,
  6. Robert A. Coburn and
  7. Marilyn E. Morris
  1. Department of Pharmaceutical Sciences, Department of Chemistry, University at Buffalo, State University of New York, Amherst, New York
  1. Address correspondence to:
    Dr. Marilyn E. Morris, Department of Pharmaceutical Sciences, 517 Hochstetter Hall, University at Buffalo, State University of New York, Amherst, NY 14260-1200. E-mail: memorris{at}buffalo.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20171145
Sep 20171147
Oct 201722317
Nov 201712713
Dec 20170122
Jan 201821611
Feb 20184218
Mar 20181106
Apr 201823112
May 201831368
Jun 2018110811
Jul 201814912
Aug 20180195
Sep 20180213
Oct 20181465
Nov 20180704
Dec 201847181
Jan 20194911
Feb 20195002
Mar 20194802
Apr 20191420
May 20191505
Jun 2019818
Jul 2019901
Aug 20191201
Oct 2019801
Nov 20192210
Dec 20192432
Jan 20201600
Feb 20201200
Mar 20201510
May 2020900
Jun 2020900
Jul 20201300
Aug 2020521
Sep 2020900
Oct 20201100
Nov 20202501
Dec 20201111
Jan 20211131
Feb 20214033
Mar 20211610
Apr 20211511
May 20211610
Jun 2021921
Jul 20211330
Aug 20211112
Sep 20211821
Oct 20212210
Nov 20213015
Dec 20212111
Jan 20221230
Feb 2022830
Mar 2022800
Apr 20221110
May 20221424
Jun 20222010
Jul 20221311
Aug 20222010
Sep 20221110
Oct 20221010
Nov 20222910
Dec 20223210
Jan 20231720
Feb 20231410
Mar 2023410

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (3)
Drug Metabolism and Disposition
Vol. 33, Issue 3
1 Mar 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS

Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
Drug Metabolism and Disposition March 1, 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS

Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
Drug Metabolism and Disposition March 1, 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
  • Absorption, Metabolism, and Excretion of Taselisib
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics